{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:45:28Z","timestamp":1793835928956,"version":"4.6.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.1093\/jnci\/djy144","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T11:07:36Z","timestamp":1532171256000},"page":"484-489","source":"Crossref","is-referenced-by-count":68,"title":["Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication"],"prefix":"10.1093","volume":"111","author":[{"given":"Ka Shing","family":"Cheung","sequence":"first","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther W","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacy, Centre for Safe Medication Practice and Research, The University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel Y S","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacy, Centre for Safe Medication Practice and Research, The University of Hong Kong, Hong Kong"},{"name":"Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Kay","family":"Seto","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C K","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacy, Centre for Safe Medication Practice and Research, The University of Hong Kong, Hong Kong"},{"name":"UCL School of Pharmacy, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai K","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"2019051009493751100_djy144-B1"},{"key":"2019051009493751100_djy144-B2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.49.3.347","article-title":"Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts","volume":"49","year":"2001","journal-title":"Gut."},{"issue":"5","key":"2019051009493751100_djy144-B3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","article-title":"Association between helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"key":"2019051009493751100_djy144-B4","doi-asserted-by":"crossref","first-page":"g3174","DOI":"10.1136\/bmj.g3174","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials","volume":"348","author":"Ford","year":"2014","journal-title":"BMJ."},{"issue":"5","key":"2019051009493751100_djy144-B5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4251\/wjgo.v10.i5.115","article-title":"Risk of gastric cancer development after eradication of Helicobacter pylori","volume":"10","author":"Cheung","year":"2018","journal-title":"World J Gastrointest Oncol."},{"issue":"6","key":"2019051009493751100_djy144-B6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3748\/wjg.v19.i6.936","article-title":"Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis","volume":"19","author":"Yoon","year":"2013","journal-title":"World J Gastroenterol."},{"issue":"10","key":"2019051009493751100_djy144-B7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and trends in diabetes among adults in the United States, 1988-2012","volume":"314","author":"Menke","year":"2015","journal-title":"JAMA."},{"issue":"12","key":"2019051009493751100_djy144-B8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat Rev Cancer."},{"issue":"13","key":"2019051009493751100_djy144-B9","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.ejca.2010.06.012","article-title":"Metformin: taking away the candy for cancer?","volume":"46","author":"Jalving","year":"2010","journal-title":"Eur J Cancer."},{"issue":"1","key":"2019051009493751100_djy144-B10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2407-11-20","article-title":"Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800, 000 individuals","volume":"11","author":"Lee","year":"2011","journal-title":"BMC Cancer."},{"issue":"9","key":"2019051009493751100_djy144-B11","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s00125-010-1804-y","article-title":"Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials","volume":"53","author":"Home","year":"2010","journal-title":"Diabetologia."},{"issue":"1","key":"2019051009493751100_djy144-B12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/dc11-0857","article-title":"Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study","volume":"35","author":"Ruiter","year":"2012","journal-title":"Diabetes Care."},{"issue":"8","key":"2019051009493751100_djy144-B13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/apt.12660","article-title":"Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study","volume":"39","author":"Kim","year":"2014","journal-title":"Aliment Pharmacol Ther."},{"key":"2019051009493751100_djy144-B14","doi-asserted-by":"crossref","first-page":"413782.","DOI":"10.1155\/2012\/413782","article-title":"The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese","volume":"2012","author":"Hsieh","year":"2012","journal-title":"Exp Diabetes Res."},{"issue":"8","key":"2019051009493751100_djy144-B15","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.18632\/aging.101019","article-title":"Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus","volume":"8","author":"Tseng","year":"2016","journal-title":"Aging (Albany NY)"},{"issue":"8","key":"2019051009493751100_djy144-B16","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jdiacomp.2015.07.017","article-title":"Diabetes mellitus and cancer of the digestive organs: an Italian population-based cohort study","volume":"29","author":"Valent","year":"2015","journal-title":"J Diabetes Complications."},{"issue":"33","key":"2019051009493751100_djy144-B17","doi-asserted-by":"crossref","first-page":"55622","DOI":"10.18632\/oncotarget.16973","article-title":"Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget."},{"issue":"4","key":"2019051009493751100_djy144-B18","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1053\/j.gastro.2008.12.045","article-title":"Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study","volume":"136","author":"Ikeda","year":"2009","journal-title":"Gastroenterology."},{"key":"2019051009493751100_djy144-B19"},{"issue":"11","key":"2019051009493751100_djy144-B20","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2017.1363","article-title":"Association between dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation","volume":"317","author":"Lau","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"2019051009493751100_djy144-B21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2015.05.002","article-title":"Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study","volume":"149","author":"Chan","year":"2015","journal-title":"Gastroenterology"},{"issue":"9","key":"2019051009493751100_djy144-B22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40264-014-0209-0","article-title":"Dosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort study","volume":"37","author":"He","year":"2014","journal-title":"Drug Saf"},{"issue":"8","key":"2019051009493751100_djy144-B23","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/pds.3780","article-title":"Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries","volume":"24","author":"Pratt","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"43","key":"2019051009493751100_djy144-B24","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.3748\/wjg.v23.i43.7716","article-title":"Epidemiology and natural history of Wilson\u2019s disease in the Chinese: a territory-based study in Hong Kong between 2000 and 2016","volume":"23","author":"Cheung","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"8","key":"2019051009493751100_djy144-B25","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1038\/ctg.2017.43","article-title":"Epidemiology and natural history of primary biliary cholangitis in the Chinese: a territory-based study in Hong Kong between 2000 and 2015","volume":"8","author":"Cheung","year":"2017","journal-title":"Clin Trans Gastroenterol"},{"key":"2019051009493751100_djy144-B26","doi-asserted-by":"crossref","first-page":"h6926","DOI":"10.1136\/bmj.h6926","article-title":"Cardiovascular outcomes associated with use of clarithromycin: population based study","volume":"352","author":"Wong","year":"2016","journal-title":"BMJ."},{"issue":"6","key":"2019051009493751100_djy144-B27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1001\/jamainternmed.2016.1586","article-title":"Association between acute neuropsychiatric events and helicobacter pylori therapy containing clarithromycin","volume":"176","author":"Wong","year":"2016","journal-title":"JAMA Intern Med."},{"issue":"2\u20133","key":"2019051009493751100_djy144-B28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000094040","article-title":"Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy","volume":"73","author":"Gu","year":"2006","journal-title":"Digestion"},{"issue":"6","key":"2019051009493751100_djy144-B29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1523-5378.2009.00722.x","article-title":"Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?","volume":"14","author":"Hung","year":"2009","journal-title":"Helicobacter"},{"issue":"1","key":"2019051009493751100_djy144-B30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","article-title":"Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study","volume":"67","author":"Cheung","year":"2018","journal-title":"Gut"},{"key":"2019051009493751100_djy144-B31"},{"issue":"5","key":"2019051009493751100_djy144-B32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol."},{"issue":"23","key":"2019051009493751100_djy144-B33","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/jnci\/djg106","article-title":"Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis","volume":"95","author":"Wang","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"2019051009493751100_djy144-B34","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/annonc\/mdt150","article-title":"Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis","volume":"24","author":"Singh","year":"2013","journal-title":"Ann Oncol"},{"issue":"12","key":"2019051009493751100_djy144-B35","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.cgh.2016.05.018","article-title":"Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis","volume":"14","author":"Tran-Duy","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"2019051009493751100_djy144-B36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1592\/phco.30.11.1159","article-title":"Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs","volume":"30","author":"McFarland","year":"2010","journal-title":"Pharmacotherapy."},{"issue":"9","key":"2019051009493751100_djy144-B37","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia."},{"issue":"9","key":"2019051009493751100_djy144-B38","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.bjc.6605024","article-title":"Proton pump inhibitors and risk of gastric cancer: a population-based cohort study","volume":"100","author":"Poulsen","year":"2009","journal-title":"Br J Cancer"},{"issue":"5","key":"2019051009493751100_djy144-B39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cgh.2017.12.009","article-title":"Effects of diabetes and glycemia control on risk of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen","volume":"16","author":"Cheuk-Fung Yip","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2019051009493751100_djy144-B40","doi-asserted-by":"crossref","first-page":"431.","DOI":"10.1007\/s12032-014-0431-8","article-title":"Insulin-like growth factor pathway aberrations and gastric cancer; evaluation of prognostic significance and assessment of therapeutic potentials","volume":"32","author":"Abdel-Rahman","year":"2015","journal-title":"Med Oncol"},{"issue":"8","key":"2019051009493751100_djy144-B41","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/pds.1926","article-title":"A basic study design for expedited safety signal evaluation based on electronic healthcare data","volume":"19","author":"Schneeweiss","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"18","key":"2019051009493751100_djy144-B42","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1300799","article-title":"Use of azithromycin and death from cardiovascular causes","volume":"368","author":"Svanstrom","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"2019051009493751100_djy144-B43","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/aje\/kwq198","article-title":"Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study","volume":"172","author":"Sturmer","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"5","key":"2019051009493751100_djy144-B44","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"1","key":"2019051009493751100_djy144-B45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.0006-341X.2000.00118.x","article-title":"Substantial gains in bias reduction from matching with a variable number of controls","volume":"56","author":"Ming","year":"2000","journal-title":"Biometrics"},{"issue":"25","key":"2019051009493751100_djy144-B46","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/111\/5\/484\/28580404\/djy144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T13:50:01Z","timestamp":1557496201000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/111\/5\/484\/5133407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,10,16]]},"published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djy144","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2018,10,16]]}}}